Silvia Dei

Biography

Formation 1989: Ph.D. in Pharmaceutical Chemistry and Technology at the University of Florence 1989-1992: Ph.D. in Chemistry Chemistry - V cycle 1992: period of study at Prof. R. Mannhold of the University of Düsseldorf (Germany) 1993 : Stock market research firm Parke-Davies 1994-1995: Postgraduate PhD at the University of Florence Academic activity 1995 - 2011: Researcher at the Faculty of Pharmacy of the University of Florence, Department of Pharmaceutical Sciences. 2011- today: Associate Professor of Pharmaceutical Chemistry at the Faculty of Pharmacy, now School of Human Health Sciences; Department of Neuroscience, Psychology, Area of ​​Pharmacy and Child Health (NEUROFARBA), Section of Pharmaceuticals and Nutraceuticals 1995-1998: Assisted in the Laboratory Exercises for Drug Analysis I and Drug Analysis II of the Degree Course in CTF, Drug Analysis I of the Diploma in Quality Control, Analysis of Medicines III of the Degree in Pharmacy and held lectures for the course of Pharmaceutical Chemistry and Toxicology I (CTF) 1998-2013: held a module on chemotherapy drugs under the course of Pharmaceutical Chemistry and Toxicology I (CTF) 1998-2004: held a module on Spectroscopic Methods in Medicinal Analysis: IR Spectroscopy in the course of the Analysis of Medicines III (Pharmacy), for which he continued to assist in the exercises. 2004-2008: has undergone the Pharmacy I course for the degree program in Quality Control in the Pharmaceutical Industry and the Course of Chemical-Toxicological Analysis I - the first module for the Degree in Environmental Toxicology . 2008-2012 has been in charge of the Analysis of Pharmacy I for the Bachelor's Degree in Applied Pharmaceutical Sciences for the Quality Control and Environmental Toxicology curricula. From da. 2012-2013 is the holder of the Pharmacy IV Training Course in Applied Pharmaceutical Sciences - Quality Control. From da. 2013-2014 is the holder of the Pharmacy Chemistry II degree in Pharmacy.

Research Interest

Silvia Dei is involved in the design, synthesis and evaluation of novel substances for the detection of active molecules from which to derive structure-activity relationships to understand the requirements for interaction with a particular biological target and to optimize their interaction. activity and / or selectivity. Particularly focused on the synthesis of active substances such as phenylalanchilamines, active substances on muscarinic and nicotinic receptor systems active substances against Multi-Drug Resistance, which can inhibit the cellular elimination of anti-tumor drugs by means of glycoprotein P, of substances capable of giving analgesia according to different mechanisms and nootropic substances.